Clinical Trial Update: Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether thromboelastography can predict the efficacy of activated recombinant Factor VII (NovoSeven) in adults with Hemophilia A or B w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Phase 1 | Status: COMPLETED